Antitumoral Activity of Molecular Hydrogen and Proton in the Treatment of Glioblastoma: An Atypical Pharmacology?
Luc Rochette, Geoffrey Dogon, Marianne Zeller, Yves Cottin, Catherine Vergely · Brain sciences · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In The sphere-forming ability of glioma cells was suppressed by hydrogen treatment, the sphere-forming ability of glioma cells was suppressed by hydrogen treatment. The authors concluded that experimental data indicate that H₂ is an antitumor agent in the treatment of glioblastoma (GBM). These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in The sphere-forming ability of glioma cells was suppressed by hydrogen treatment.
What the Researchers Studied
The researchers studied The sphere-forming ability of glioma cells was suppressed by hydrogen treatment. The study used a in vitro cell-culture laboratory experiment.
What Effects Did Molecular Hydrogen Have?
Protons (H+) and molecular hydrogen (H₂) interact in the cell and are essential in a wide variety of processes. The antioxidant, anti-inflammatory, and antiapoptotic effects of H₂ have been studied in numerous experimental and clinical studies. Experimental data indicate that H₂ is an antitumor agent in the treatment of glioblastoma (GBM). The sphere-forming ability of glioma cells was suppressed by hydrogen treatment.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was The sphere-forming ability of glioma cells was suppressed by hydrogen treatment. The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.